Financial aid for Danish applicants to European research and innovation: EUopSTART

Financial aid for Danish applicants to European research and innovation: EUopSTART

14-12-2018

Danish SMEs looking to apply to European research and innovation programmes can receive financial aid to prepare their grant application, including expenses in external assistance. With the EUopSTART programme, you can receive funding for external assistance to your application to programmes such as ERC, SME Instrument, Fast Track to Innovation and Eurostars.

EUopSTART

The EUopSTART is an initiative of the Ministry of Higher Education and Science from Denmark with the goal of increasing the participation of Danish research institutions and enterprises in European research and innovation programmes.

What do you receive?

You receive up to 50% of your costs paid by this grant. Costs that are eligible for funding are: payroll costs, travel costs and external assistance. External assistance is allowed to be maximum 70% of the total project budget.

Depending on the grant type you are applying for and the role in this application *coordinator or partner) you can request budgets up to DKK 50,000/€7,000 or DKK 75,000/€10,000. The project duration must be at least one month.

Who can apply?

Research-intensive SMEs seeking to apply to the Eurostars programme, which:

  • Have been in existence for at least 12 months at the time of application;
  • Are able to document that they have the scientific and financial resources to complete their share of the Eurostars project;
  • Have not been declared bankrupt or be in suspension of payments;
  • Have generated turnover of at least ~€140,000 or have attracted external capital equivalent of at least ~€70,000 or have had at least two fulltime employees within the last financial year;
  • Have no debts to any public authority (including any debts to a public authority for which the payment-due date has been exceeded).
  • Have received no more than €200,000 of state aid in the 3 years before the time of application.

Catalyze and EUopSTART

We can make an EUopSTART application for you, which allows you to have our support for a grant application for a much lower cost. We have an office in Denmark and dedicated life science experts who specialise in making funding applications. Here’s how it works:

  • PICK THE RIGHT CALL: After listening to your ideas and ambitions, we assess which call is more suitable for your project ideas
  • We make your EUopSTART application
  • When granted, we help you make an application for the chosen funding opportunity
    • FIND PARTNERS: We use our extensive life science network to find partners for a high quality, interdisciplinary consortium
    • PROPOSAL DEVELOPMENT: We coordinate and develop a strong project proposal, including budgeting.
    • SUBMISSION: We coordinate all requirements and formalities for grant application submission
  • PROJECT GRANTED: We set up consortium agreements and negotiate with the grant agencies on budgets and terms of the grant.’

Contact us

Are you interested or do you have questions? Contact us via the form below and we will get in touch.



Photo by Matthew Henry on Unsplash

Thinking about starting your own biotech company?

Thinking about starting your own biotech company?

12-12-2018 by Benjamin Sieters You are an academic researcher with a brilliant idea or some very promising results in your recent experiments. Now you’re thinking of starting your own biotech company to actually bring your invention from the lab to the market. Making the step from academic research to biotech entrepreneurship Here are some aspects… Continue Reading

Need to assess the technical and commercial feasibility of your innovation?

Need to assess the technical and commercial feasibility of your innovation?

29-11-2018 by Saharla Ahmed Are you an SME with a ground-breaking concept, but unsure of its commercial potential? Do you have a platform technology and need to identify new and marketable applications to boost the growth of your company? An initial business plan that needs further elaboration? If so, a feasibility study is key to… Continue Reading

Preparing a H2020 proposal and navigating the proposal template: our tips and tricks

Preparing a H2020 proposal and navigating the proposal template: our tips and tricks

23-11-2018 by Max van Zandvoort The prestigious H2020 programme by the European Commission includes several types of actions. One of these are the so-called Research & Innovation Actions (RIA), which are aimed to create new knowledge and/or to explore the feasibility of translating this knowledge into innovative applications, through an international collaborative effort. RIAs provide… Continue Reading

Discovering the role of big data in driving early infectious disease detection

Discovering the role of big data in driving early infectious disease detection

8-11-2018 by Marike van Beuge Since the introduction of antimicrobials, starting with penicillin in the 20th century, these life-saving drugs have revolutionised our society and economy. Previously deadly diseases have become routine ailments, requiring little more than a brief treatment. However, due to a range of factors, including rising antimicrobial resistance, infectious disease threats are (re-)emerging, … Continue Reading

Catalyze wins FD Gazellen award

Catalyze wins FD Gazellen award

Earlier this year Catalyze opened new offices in Denmark and Switzerland, becoming a truly international company with its headquarter in Amsterdam. Now, Catalyze receives a FD Gazellen award, meaning that it is one of the fastest growing companies in the Netherlands. “We are very proud to receive this award. It is a great acknowledgement for… Continue Reading

Future topics for IMI call 17 published

Future topics for IMI call 17 published

New future topics draft texts for IMI call 17 have been published. Although these topics are not final yet, it is at this stage unlikely that they will change. We have summarised the most important information below. Optimising future obesity treatment The aim of this topic is to identify pathophysiologically and clinically meaningful subgroups of… Continue Reading

Added value Catalyze

Why choose Catalyze?


Scientific & academic

experts

Team of consultants with scientific and academic excellence (PhD, MD)

Commercial

experts

Consultants with experience in translating research into commercial products

Life sciences

biotechnology

Specialized in life sciences, biotechnology and medical technology.

Strong

network

Strong network of reliable and professional partners in the field.

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or